Quarterly Cash Flow Report
Highlights: Completion of Phase 1 Clinical Trial; PBT434 found to be safe and well-tolerated; clinically tested doses achieve concentrations
Read MoreInvestor Centre
Investor Resources
Investor presentations
| June 4, 2019 | Alterity Therapeutics Investor Presentation for FNN | 1 MB | |
| May 9, 2019 | Alterity Therapeutics AAN Presentation | 755 KB | |
| April 10, 2019 | Alterity Therapeutics Investor Presentation | 2 MB | |
| January 8, 2018 | Prana Biotechnology JPM investor presentation | 3 MB | |
| January 8, 2018 | Biotech Showcase Presentation | 3 MB | |
| January 8, 2018 | Biotechnology Biotech Showcase Investor Presentation | 3 MB | |
| April 22, 2016 | World Orphan Drug Congress Presentation | 3 MB | |
| July 17, 2014 | AAIC Panel Presentation – Colin Masters | 3 MB | |
| February 18, 2014 | Reach2HD Clinical Results Investor Presentation | 1 MB |
ASX Announcements
2019
2018
| February 10, 2019 | Appendix 3B – Cleansing Notice – Feb 2018 | 362 KB | |
| January 7, 2019 | Form 603 – Notice of Initial Substantial Holder Morgan Stanley – Jan 2018 | 543 KB | |
| January 7, 2019 | Form 603 – Notice of Initial Substantial Holder MUFG – Jan 2018 | 457 KB | |
| January 7, 2019 | Appendix 3B – Jan 2018 | 955 KB | |
| December 23, 2018 | PBT Trading Halt – Dec 2018 | 459 KB | |
| December 4, 2018 | Form S-8 Dec 2018 | 271 KB | |
| November 19, 2018 | Appendix 3B – Nov 2018 | 940 KB | |
| November 19, 2018 | Appendix 3Y Change of Director’s Interest Notice – Nov 2018 | 456 KB | |
| November 16, 2018 | Results of AGM 2018 | 186 KB | |
| November 16, 2018 | AGM Presentation – Nov 2018 | 621 KB | |
| October 16, 2018 | Notice of AGM – Oct 2018 | 849 KB | |
| July 16, 2018 | Appendix 3B and 708A Notice – Jul 2018 | 248 KB | |
| June 27, 2018 | Investor Presentation – Jun 2018 | 5 MB | |
| January 22, 2018 | Appendix 3B – Jan 2018 | 809 KB |
2017
| June 7, 2017 | Appendix 3B – Jun 2017 | 814 KB | |
| June 26, 2017 | Change of Address – June 2017 | 366 KB | |
| September 26, 2017 | Change of Address -Sept 2017 | 619 KB | |
| October 11, 2017 | Form F-3 Oct 2017 | 255 KB | |
| October 16, 2017 | Notice of AGM – Oct 2017 | 8 MB | |
| November 9, 2017 | Prospectus Supplement – Nov 2017 | 149 KB | |
| November 9, 2017 | Form 6-K Nov 2017 | 70 KB | |
| November 17, 2017 | Results of AGM 2017 | 92 KB | |
| November 17, 2017 | AGM Presentation 2017 | 980 KB | |
| December 19, 2017 | Appendix 3B – Dec 2017 | 810 KB | |
| December 22, 2017 | Appendix 3Y Change of Director’s Interest GPK – Dec 2017 | 534 KB | |
| December 22, 2017 | Appendix 3Y – Change of Director’s Interest BM – Dec 2017 | 533 KB | |
| December 22, 2017 | Appendix 3Y – Change of Director’s Interest GM – Dec 2017 | 533 KB | |
| December 22, 2017 | Appendix 3Y – Change of Director’s Interest LG – Dec 2017 | 532 KB | |
| December 22, 2017 | Appendix 3Y Change of Director’s Interest PM – Dec 2017 | 532 KB |
2016
| March 29, 2016 | PBT Completes Ratio Change on NASDAQ – Mar 2016 | 377 KB | |
| April 22, 2016 | Prana Presents at World Orphan Drug Congress – Apr 2016 | 3 MB | |
| October 14, 2016 | Form-6k Oct 2016 | 263 KB | |
| October 14, 2016 | Prospectus Supplement – Oct 2016 | 201 KB | |
| October 14, 2016 | Notice of AGM – Oct 2016 | 9 MB | |
| November 17, 2016 | Results of AGM – Nov 2017 | 65 KB | |
| May 10, 2019 | Prana Completes Ratio Change on NASDAQ – Mar 2016 | 377 KB |
2015
| February 13, 2015 | FDA notification – Feb 2015 | 378 KB | |
| February 18, 2015 | Appendix 3B and s708A Notice – Feb 2015 | 169 KB | |
| April 28, 2015 | PBT2 Recommended for Orphan Designation Europe – Apr 2015 | 139 KB | |
| May 27, 2015 | Appendix 3B and s708A Notice – May 2015 | 559 KB | |
| June 2, 2015 | Appendix 3Y – Change of Directors Interest – Jun 2015 | 52 KB | |
| August 26, 2015 | Appendix 4G – Jun 2015 | 202 KB | |
| August 27, 2015 | Annual Report and 4E – Jun 2015 | 8 MB | |
| October 12, 2015 | Notice of AGM – 2015 | 575 KB | |
| November 12, 2015 | AGM Presentation 2015 | 786 KB | |
| November 13, 2015 | Results of AGM – 2015 | 68 KB | |
| November 16, 2015 | AGM Presentation – 2015 | 645 KB | |
| March 10, 2016 | ADR Rati Change – Mar 2016 | 95 KB |
2014
2013
| July 17, 2013 | Notice of Ceasing to be a Substantial Shareholder – July 2013 | 32 KB | |
| July 17, 2013 | Share Purchase Plan 2013 Offer Document – Jul 2013 | 220 KB | |
| July 17, 2013 | Prana Share Purchase Plan Closed – May 2013 | 30 KB | |
| September 9, 2013 | Appendix 3B – Dec 2013 | 100 KB | |
| September 9, 2013 | Appendix 3B – Feb 2013 | 101 KB | |
| September 9, 2013 | Appendix 3B – Jan 2013 | 101 KB | |
| September 9, 2013 | Appendix 3B – May 2013 | 101 KB | |
| September 9, 2013 | Appendix 3B – Oct 2013 | 288 KB |
2012
2011
2010
2009
2008
2007
| August 27, 2013 | Appendix 4C – Sept 2007 | 41 KB | |
| August 27, 2013 | Appendix 4C – Mar 2007 | 89 KB | |
| August 27, 2013 | Appendix 4C – Jun 2007 | 41 KB | |
| August 26, 2013 | Form-6K Mar 2007 | 1 MB |
2006
| August 26, 2013 | Form 6K – Mar 2006 | 1 MB | |
| August 26, 2013 | Appendix 4D – Dec 2006 | 584 KB |
2005
| August 26, 2013 | Form 6K – Mar 2005 | 564 KB | |
| August 26, 2013 | Appendix 4D – Dec 2005 | 139 KB |
2004
| August 26, 2013 | Appendix 4D – Dec 2004 | 262 KB |
Financial reports
2019
| August 1, 2019 | Appendix 4C – June 2019 | 151 KB | |
| May 13, 2019 | Form-6-K-2019_03_01 | 400 KB | |
| April 16, 2019 | Appendix 4C – Mar 2019 | 161 KB | |
| February 28, 2019 | Form 6-K – Mar 2019 | 400 KB | |
| February 28, 2019 | Appendix 4D 2018 | 217 KB | |
| January 31, 2019 | Appendix 4C – Dec 2018 | 234 KB |
2018
| May 13, 2019 | Form 6-K Feb 2018 | 148 KB | |
| October 30, 2018 | Appendix 4C – Sept 2018 | 170 KB | |
| September 3, 2018 | Form 20F – 2018 | 2 MB | |
| August 31, 2018 | Appendix 4G FY Ended 2018_06_30 | 123 KB | |
| August 31, 2018 | Annual Report 2018 | 2 MB | |
| July 30, 2018 | Appendix 4C – Jun 2018 | 262 KB | |
| May 7, 2018 | Appendix 4C – Mar 2018 | 263 KB | |
| March 4, 2018 | Form 6-K Feb 2018 | 148 KB |
2017
| June 7, 2019 | Appendix 4C – Dec 2017 | 700 KB | |
| May 13, 2019 | Form 6-K 2017 | 70 KB | |
| March 4, 2018 | Appendix 4D – Dec 2017 | 275 KB | |
| January 30, 2018 | Appendix 4C – December 2017 | 700 KB | |
| October 30, 2017 | Appendix 4C – Sept 2017 | 699 KB | |
| September 1, 2017 | Form 20-F2017 | 822 KB | |
| August 31, 2017 | Annual Report 2017 | 2 MB | |
| August 1, 2017 | Appendix 4C – Jun 2017 | 698 KB | |
| May 10, 2017 | Appendix 4C – Mar 2017 | 52 KB | |
| February 24, 2017 | Form 6-K Feb 2017 | 221 KB |
2016
| June 7, 2019 | Appendix 4E – June 2016 | 586 KB | |
| February 24, 2017 | Appendix 4D – 2016 | 282 KB | |
| January 30, 2017 | Appendix 4C – Dec 2016 | 265 KB | |
| October 30, 2016 | Appendix 4C – Sept 2016 | 265 KB | |
| October 4, 2016 | Form 20-F2016 | 907 KB | |
| October 2, 2016 | Annual Report 2016 | 3 MB | |
| July 26, 2016 | Appendix 4C – June 2016 | 248 KB | |
| April 29, 2016 | Appendix 4C – Mar 2016 | 179 KB | |
| February 25, 2016 | Form 6-K Feb 2016 | 170 KB |
2015
| February 25, 2016 | Appendix 4D – 2015 | 1 MB | |
| January 29, 2016 | Appendix 4C – Dec 2015 | 182 KB | |
| October 30, 2015 | Appendix 4C – Sept 2015 | 179 KB | |
| August 26, 2015 | Form 20-F2015 | 836 KB | |
| August 26, 2015 | Annual Report 2015 | 8 MB | |
| July 27, 2015 | Appendix 4C – Jun 2015 | 55 KB | |
| April 28, 2015 | Appendix 4C – Mar 2015 | 76 KB | |
| February 24, 2015 | Form 6-K 2015 | 132 KB |
2014
| February 24, 2015 | Appendix 4D – 2014 | 2 MB | |
| January 30, 2015 | Appendix 4C – Dec 2014 | 55 KB | |
| November 19, 2014 | Appendix 4C – Mar 2014 | 71 KB | |
| November 13, 2014 | Appendix 4C – Sept 2014 | 60 KB | |
| October 1, 2014 | Annual Report 2014 | 8 MB | |
| September 1, 2014 | Appendix 4E – 2014 | 407 KB | |
| July 31, 2014 | Appendix 4C – Jun 2014 | 81 KB |
2013
| June 7, 2019 | Form 20-F2013 | 2 MB | |
| April 28, 2014 | Appendix 4C – Dec 2013 | 61 KB | |
| March 4, 2014 | Appendix 4D – 2013 | 2 MB | |
| February 9, 2014 | Annual Report 2013 | 2 MB | |
| November 27, 2013 | Appendix 4C – Sept 2013 | 64 KB | |
| August 27, 2013 | Appendix 4C – Mar 2013 | 60 KB | |
| August 27, 2013 | Appendix 4C – Jun 2013 | 61 KB | |
| August 26, 2013 | Form 6K – Feb 2013 | 118 KB |
2012
| June 7, 2019 | Appendix 4D – Dec 2012 | 1 MB | |
| June 7, 2019 | Appendix 4C – Sept 2012 | 149 KB | |
| August 27, 2013 | Appendix 4C – Mar 2012 | 59 KB | |
| August 27, 2013 | Appendix 4C – Jun 2012 | 59 KB | |
| August 27, 2013 | Appendix 4C – Dec 2012 | 59 KB | |
| August 26, 2013 | Annual Report 2012 | 4 MB | |
| August 26, 2013 | Form 20-F2012 | 2 MB |
2011
| June 7, 2019 | Appendix 4C – Dec 2011 | 59 KB | |
| June 7, 2019 | Appendix 4C – Sept 2011 | 59 KB | |
| June 7, 2019 | Appendix 4C – Mar 2011 | 59 KB | |
| September 9, 2013 | Form 6K- May 2011 | 149 KB | |
| September 9, 2013 | Form 6K – Jul 2011 | 190 KB | |
| August 27, 2013 | Appendix 4C-June 2011 | 59 KB | |
| August 26, 2013 | Appendix 4D -Dec 2011 | 855 KB | |
| August 26, 2013 | Annual Report 2011 | 3 MB | |
| August 26, 2013 | Form 20-F 2011 | 664 KB |
2010
| August 26, 2013 | Annual Report 2010 | 2 MB | |
| August 26, 2013 | Appendix 4D – Dec 2010 | 983 KB | |
| August 27, 2013 | Appendix 4C – Jun 2010 | 63 KB | |
| August 27, 2013 | Appendix 4C- Mar 2010 | 66 KB | |
| June 7, 2019 | Appendix 4C – Dec 2010 | 59 KB | |
| June 7, 2019 | Appendix 4C – Sept 2010 | 59 KB | |
| June 7, 2019 | Form 6-K Feb 2010 | 99 KB | |
| June 7, 2019 | Form 20F – Jun 2010 | 1 MB |
2009
| June 7, 2019 | Form 20F – 2009 | 1 MB | |
| June 7, 2019 | Form 6-K Feb 2009 | 107 KB | |
| August 27, 2013 | Appendix 4C – Sept 2009 | 122 KB | |
| August 27, 2013 | Appendix 4C – Mar 2009 | 79 KB | |
| August 27, 2013 | Appendix 4C – Jun 2009 | 77 KB | |
| August 27, 2013 | Appendix 4C – Dec 2009 | 65 KB | |
| August 26, 2013 | Appendix 4D – Dec 2009 | 1 MB | |
| August 26, 2013 | Annual Report 2009 | 2 MB |
2008
| June 7, 2019 | Form 20-F 2008 | 6 MB | |
| June 7, 2019 | Appendix 4C – December 2008 | 79 KB | |
| August 27, 2013 | Appendix 4C – Sept 2008 | 78 KB | |
| August 27, 2013 | Appendix 4C – Mar 2008 | 77 KB | |
| August 27, 2013 | Appendix 4C – Jun 2008 | 76 KB | |
| August 26, 2013 | Form 6-K Feb 2008 | 152 KB | |
| August 26, 2013 | Appendix 4D – Dec 2008 | 864 KB | |
| August 26, 2013 | Annual Report 2008 | 1 MB |
2007
| June 7, 2019 | Form 20-F 2007 | 15 MB | |
| June 7, 2019 | Appendix 4C – Dec 2007 | 76 KB | |
| August 26, 2013 | Appendix 4D – Dec 2007 | 578 KB | |
| August 26, 2013 | Annual Report 2007 | 3 MB |
2006
| June 7, 2019 | Appendix 4C – Sept 2006 | 76 KB | |
| June 7, 2019 | Form 20-F 2006 | 935 KB | |
| August 26, 2013 | Annual Report 2006 | 2 MB |
2005
| August 26, 2013 | Annual Report 2005 | 2 MB | |
| August 27, 2013 | Appendix 4C – Dec 2005 | 136 KB | |
| June 7, 2019 | Form 20-F 2005 | 9 MB |
2004
| June 7, 2019 | Form 20-F 2004 | 403 KB | |
| August 27, 2013 | Appendix 4C – Sept 2004 | 30 KB | |
| August 27, 2013 | Appendix 4C – March 2004 | 25 KB | |
| August 27, 2013 | Prana-Appendix-4C-2004-Jun | 25 KB | |
| August 27, 2013 | Prana-Appendix-4C-2004-Dec | 30 KB | |
| August 26, 2013 | Annual Report 2004 | 573 KB |
2003
| June 7, 2019 | Form 20-F 2003 | 4 MB | |
| August 26, 2013 | Appendix 4D – Dec 2003 | 84 KB | |
| August 26, 2013 | Annual Report 2003 | 869 KB |
2002
| August 26, 2013 | Annual Report 2002 | 606 KB |
2001
| August 26, 2013 | Annual Report 2001 | 4 MB |
Corporate governance
| May 15, 2019 | Board Charter | 1 MB | |
| May 15, 2019 | ATH Constitution | 414 KB | |
| May 15, 2019 | Diversity Policy | 197 KB | |
| May 15, 2019 | Securities Trading Policy | 343 KB | |
| May 15, 2019 | Whistle Blower Policy | 320 KB |
News
Alterity Therapeutics Announces Successful Completion of Phase 1 Clinical Trial
Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) today announced that it has successfully comple
Read More
Alterity Therapeutics talks to Finance News Network
Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, discusses the company’s development pipeline and lead drug
Read More
Alterity Therapeutics’ Finance News Network Presentation
On June 6 2019, Alterity Therapeutics Limited (ASX:ATH) CEO & Chairman, Geoffrey Kempler, participated in the Finance News Network Inv
Read MoreReceive news from Alterity Therapeutics
